These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 12664945
21. Promoting life?: Embryonic stem cell research legislation. Miller JF. Cathol Univers Law Rev; 2003; 52(2):437-79. PubMed ID: 15214335 [No Abstract] [Full Text] [Related]
22. Stem cell research: magical promise v. moral peril. Orr RD, Hook CC. Yale J Health Policy Law Ethics; 2001; 2(1):109, 189-99. PubMed ID: 12664944 [No Abstract] [Full Text] [Related]
23. Washington insider: federal funding for embryonic stem cell research. Doerflinger RM. Natl Cathol Bioeth Q; 2005; 5(3):455-62. PubMed ID: 16425497 [No Abstract] [Full Text] [Related]
24. Battle lines shift in stem-cell funding fight...as non-profit companies enter the fray. Smaglik P. Nature; 2000 May 04; 405(6782):6. PubMed ID: 10811186 [No Abstract] [Full Text] [Related]
26. Stem cell research and conditional federal funding: do state laws allowing more extensive research pose a problem for federalism? Schiller C. Pepperdine Law Rev; 2004 May 13; 31(4):1017-54. PubMed ID: 16514766 [No Abstract] [Full Text] [Related]
27. Misapplied ethical considerations: U.S. federal stem cell mandates lack global focus and market foresight. Fowler HL. Cornell Int Law J; 2004 May 13; 36(3):521-44. PubMed ID: 16602208 [No Abstract] [Full Text] [Related]
28. Stem cells. Deriving 'controversy-free' ES cells is controversial. Vogel G. Science; 2005 Oct 21; 310(5747):416-7. PubMed ID: 16239442 [No Abstract] [Full Text] [Related]
29. The moral, ethical, and legal controversy surrounding pluripotent stem cell research. Doody K. Loyola Law Rev; 2002 Oct 21; 48(2):267-326. PubMed ID: 15156885 [No Abstract] [Full Text] [Related]
30. The ethics of control. Charo RA. Yale J Health Policy Law Ethics; 2001 Oct 21; 2(1):109, 143-55. PubMed ID: 12664940 [No Abstract] [Full Text] [Related]
31. Washington Insider: Congressional impasse on human cloning. Doerflinger RM. Natl Cathol Bioeth Q; 2004 Oct 21; 4(1):19-25. PubMed ID: 15192847 [No Abstract] [Full Text] [Related]
33. Stem-cell lines. Wall St J (East Ed); 2005 May 26; ():A12. PubMed ID: 15966127 [No Abstract] [Full Text] [Related]
34. President's Council on Bioethics: reproduction and responsibility. Doerflinger RM. Natl Cathol Bioeth Q; 2004 May 26; 4(3):461-9. PubMed ID: 15452926 [No Abstract] [Full Text] [Related]
35. The California gambit. The Golden State has launched a 3bn dollar wager on stem cell science. Gibbs WW. Sci Am; 2005 Jul 26; 293(1):A24-7. PubMed ID: 16008298 [No Abstract] [Full Text] [Related]
37. The bioethics agenda and the Bush second term. Cohen E. New Atlantis; 2006 Sep 26; 7():11-8. PubMed ID: 15812948 [No Abstract] [Full Text] [Related]
38. A scientific rationale for human embryonic stem cell research. Kaufman DS. Yale J Health Policy Law Ethics; 2001 Sep 26; 2(1):109, 177-87. PubMed ID: 12664943 [No Abstract] [Full Text] [Related]
39. Stem cell research: is the law preventing progress? Enmon JL. Utah Law Rev; 2002 Sep 26; (3):621-48. PubMed ID: 15156897 [No Abstract] [Full Text] [Related]
40. Balancing science, ethics and politics: stem cell research, a paradigm case. Pellegrino ED. J Contemp Health Law Policy; 2002 Sep 26; 18(3):591-611. PubMed ID: 12491656 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]